

News
Categories
Sign up
Featured Posts


Archive


- Jan 2, 2022
Alpha DaRT Investigator Meeting in Las Vegas

- Nov 4, 2021
Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)


- Oct 26, 2021
Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective

- Oct 12, 2021
Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM


- Jul 11, 2021
Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company


- Jul 8, 2021
First Alpha DaRT Patient Treated in the US as Part of Pilot Multicenter Skin Cancer Trial

- Jun 8, 2020
Israeli medical device maker Alpha Tau raises $26 million to fund trials

- Jun 4, 2020
Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round

- Jun 3, 2020
Lela’s Story of her Cancer Treatment Journey that Brought her to Alpha DaRT

- Apr 7, 2020
Alpha Tau Medical Announces Exclusive Distribution Arrangement with Medison Canada For Breakthrough